CD8A and Alzheimer disease: The finding that immune checkpoint blockade targeting PD-1 reduces AD pathologies in 5xFAD mice [9] can be used as supporting evidence to the theory that checkpoint blockade rejuvenates the protective function of exhausted PD-1+ regulatory CD8+ T cells.